303 related articles for article (PubMed ID: 19350459)
1. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
Scholler N
IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
[No Abstract] [Full Text] [Related]
2. Giving Up on Precision Oncology? Not So Fast!
Warner JL
Clin Transl Sci; 2017 May; 10(3):128-129. PubMed ID: 28146309
[No Abstract] [Full Text] [Related]
3. Transport Barriers and Oncophysics in Cancer Treatment.
Nizzero S; Ziemys A; Ferrari M
Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312
[TBL] [Abstract][Full Text] [Related]
4. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
5. JAMA Oncology Patient Page. The Evolution of a Cancer.
West HJ; Jin JO
JAMA Oncol; 2015 Sep; 1(6):850. PubMed ID: 26247697
[No Abstract] [Full Text] [Related]
6. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
7. Targeting Biophysical Cues: a Niche Approach to Study, Diagnose, and Treat Cancer.
Zhang SX; Liu L; Zhao W
Trends Cancer; 2018 Apr; 4(4):268-271. PubMed ID: 29606309
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring in oncology: does it have a future?
McMahon G; O'Connor R
Bioanalysis; 2009 Jun; 1(3):507-11. PubMed ID: 21083145
[No Abstract] [Full Text] [Related]
9. Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer.
Sharma AK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):iii-iv. PubMed ID: 29857038
[No Abstract] [Full Text] [Related]
10. Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
Masters GA; Krilov L; Bailey HH; Brose MS; Burstein H; Diller LR; Dizon DS; Fine HA; Kalemkerian GP; Moasser M; Neuss MN; O'Day SJ; Odenike O; Ryan CJ; Schilsky RL; Schwartz GK; Venook AP; Wong SL; Patel JD
J Clin Oncol; 2015 Mar; 33(7):786-809. PubMed ID: 25605863
[No Abstract] [Full Text] [Related]
11. Therapeutic Drug Monitoring in Oncology.
Wilkinson DS
Ther Drug Monit; 2019 Oct; 41(5):551-552. PubMed ID: 31318845
[No Abstract] [Full Text] [Related]
12. The translational potential of circulating tumour DNA in oncology.
Patel KM; Tsui DW
Clin Biochem; 2015 Oct; 48(15):957-61. PubMed ID: 25889059
[TBL] [Abstract][Full Text] [Related]
13. Abstracts of the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. October 22-26, 2007. San Francisco, California, USA.
Mol Cancer Ther; 2007 Dec; 6(12 Pt 2):3331s-704s. PubMed ID: 18300399
[No Abstract] [Full Text] [Related]
14. Validation of analytic methods for biomarkers used in drug development.
Chau CH; Rixe O; McLeod H; Figg WD
Clin Cancer Res; 2008 Oct; 14(19):5967-76. PubMed ID: 18829475
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing in cancer therapeutics.
Ezzeldin HH; Diasio RB
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
[No Abstract] [Full Text] [Related]
16. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
[TBL] [Abstract][Full Text] [Related]
17. A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancer.
Shore ND; Concepcion R; Barocas DA
Hosp Pract (1995); 2013; 41(4):78-80. PubMed ID: 24145592
[TBL] [Abstract][Full Text] [Related]
18. First advanced course on biomarkers in molecular and immuno-oncology in the Middle East.
Moujaess E; Khoury M; Zouein J; Eid JB; Mohty R; Kourie HR
Future Oncol; 2021 Aug; 17(22):2831-2834. PubMed ID: 34148366
[TBL] [Abstract][Full Text] [Related]
19. Pharmacometrics and systems biology in oncology: is there an intersection?
Kloft C
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):89-90. PubMed ID: 23260011
[No Abstract] [Full Text] [Related]
20. The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery.
El Bairi K; Atanasov AG; Amrani M; Afqir S
Biomed Pharmacother; 2019 Jan; 109():2492-2498. PubMed ID: 30551510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]